Denali Therapeutics Inc.DNLINASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank30
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P30
Within normal range
vs 5Y Ago
-3.2x
Contraction
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
2025-14.57%-34.3%
2024-10.85%+13.8%
2023-12.58%-67.3%
2022-7.52%-85.4%
2021-4.06%-189.7%
20204.53%+144.5%
2019-10.18%-516.8%
20182.44%+107.2%
2017-33.97%+40.4%
2016-56.96%-